Study of STAT3 Expression in Different Phases of Patients with Chronic Myeloid Leukemia

Study of STAT3 Expression in Different Phases of Patients with Chronic Myeloid Leukemia

Background and Aim: Chronic myeloid leukemia(CML) is a clonal myeloproliferative disease, characterized by BCR/ABL translocation. Using tyrosine kinase inhibitors such as Imatinib, treatment for this disease has progressed remarkably. However, resistance to tyrosine kinase inhibitor is a major obsta...

Full description

Bibliographic Details
Main Authors: Peyman Yousefi, Shahrbano Rostami, Nasrin Alizadeh Ghandfurosh, Saeed Mohammadi, Mohsen Nikbakht, Laya Ghadyaninejhad, Bahram Chahardouli
Format: Article
Language:fas
Published: Tehran University of Medical Sciences 2019-07-01
Series:پیاورد سلامت
Subjects:
chronic myeloid leukemia
stat3
imatinib
drug resistance
Online Access:http://payavard.tums.ac.ir/article-1-6760-en.html

Internet

http://payavard.tums.ac.ir/article-1-6760-en.html

Similar Items